USPTO Grants Two New Patents to Metabolon

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., the leader in metabolomics, biomarker discovery and biochemical analysis, announces that it was awarded two new US Patents. With the grant of these patents Metabolon currently holds 17 US Patents related to its biochemical profiling methods, data analysis solutions and biomarkers for disease and toxicity.

Back to news